Dentsply International Inc. (XRAY) Shares Sold by Kalmar Investments Inc. DE

Kalmar Investments Inc. DE reduced its stake in Dentsply International Inc. (NASDAQ:XRAY) by 21.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 383,839 shares of the company’s stock after selling 107,881 shares during the period. Kalmar Investments Inc. DE’s holdings in Dentsply International were worth $23,813,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the company. BlueMountain Capital Management LLC acquired a new stake in Dentsply International during the first quarter valued at about $953,000. Bank of Montreal Can acquired a new stake in Dentsply International during the second quarter valued at about $15,419,000. Harvey Investment Co. LLC raised its stake in Dentsply International by 0.3% in the second quarter. Harvey Investment Co. LLC now owns 190,561 shares of the company’s stock valued at $11,822,000 after buying an additional 499 shares during the period. HBK Investments L P acquired a new stake in Dentsply International during the first quarter valued at about $512,000. Finally, Sumitomo Mitsui Trust Holdings Inc. raised its stake in Dentsply International by 12.7% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 786,336 shares of the company’s stock valued at $48,784,000 after buying an additional 88,725 shares during the period. 94.61% of the stock is currently owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Dentsply International (NASDAQ:XRAY)

Dentsply International Inc. (NASDAQ:XRAY) traded up 0.59% during trading on Wednesday, reaching $59.41. 1,193,775 shares of the company’s stock were exchanged. Dentsply International Inc. has a 12-month low of $53.43 and a 12-month high of $65.83. The stock’s 50-day moving average is $59.63 and its 200-day moving average is $61.26.

Dentsply International (NASDAQ:XRAY) last posted its quarterly earnings data on Friday, August 5th. The company reported $0.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.70 by $0.06. The company had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.03 billion. Dentsply International had a net margin of 11.99% and a return on equity of 9.18%. The firm’s revenue was up 46.4% compared to the same quarter last year. During the same quarter last year, the firm posted $0.73 earnings per share. On average, analysts anticipate that Dentsply International Inc. will post $2.76 earnings per share for the current year.

The firm also recently disclosed a dividend, which was paid on Friday, October 14th. Investors of record on Friday, September 30th were issued a $0.0775 dividend. The ex-dividend date of this dividend was Wednesday, September 28th. Dentsply International’s payout ratio is 14.49%.

Several analysts have recently issued reports on XRAY shares. Bank of America Corp. started coverage on shares of Dentsply International in a research report on Monday, September 12th. They issued a “buy” rating and a $70.00 price target on the stock. JPMorgan Chase & Co. started coverage on shares of Dentsply International in a research report on Thursday, September 22nd. They issued a “neutral” rating and a $65.00 price target on the stock. Zacks Investment Research lowered shares of Dentsply International from a “buy” rating to a “hold” rating in a research report on Monday, August 8th. Piper Jaffray Cos. reissued a “buy” rating on shares of Dentsply International in a research report on Monday, June 27th. Finally, Barrington Research lowered shares of Dentsply International from an “outperform” rating to a “market perform” rating in a research report on Monday, August 8th. Six analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $66.91.

In related news, SVP Maureen J. Macinnis sold 45,100 shares of the firm’s stock in a transaction that occurred on Thursday, August 25th. The shares were sold at an average price of $60.55, for a total value of $2,730,805.00. Following the transaction, the senior vice president now owns 36,730 shares of the company’s stock, valued at $2,224,001.50. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, VP Rainer Berthan sold 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 6th. The stock was sold at an average price of $61.12, for a total transaction of $305,600.00. Following the completion of the transaction, the vice president now directly owns 34,370 shares in the company, valued at approximately $2,100,694.40. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by corporate insiders.

Dentsply International Company Profile

DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.

5 Day Chart for NASDAQ:XRAY

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dentsply International Inc. (NASDAQ:XRAY).

Receive News & Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

McDonald’s Keeping As Much As 25% in Hong Kong and China Stores
McDonald’s Keeping As Much As 25% in Hong Kong and China Stores
President Obama Take Steps to Block Chip Maker Acquisition by Chinese Company
President Obama Take Steps to Block Chip Maker Acquisition by Chinese Company
GoPro Planning to Cut 200 Jobs
GoPro Planning to Cut 200 Jobs
Early Data from Cyber Monday Shows Sales Increasing Over 9%
Early Data from Cyber Monday Shows Sales Increasing Over 9%
Retailers Anticipating Strong Support for Small Business Saturday
Retailers Anticipating Strong Support for Small Business Saturday
Eli Lilly Alzheimer’s Drug Does Not Pass the Test
Eli Lilly Alzheimer’s Drug Does Not Pass the Test


 
© 2006-2016 Ticker Report. Google+.